Psagot Value Holdings’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-4,316
| Closed | -$5K | – | 336 |
|
|
2017
Q3 | $5K | Buy |
4,316
+373
| +9% | +$432 | ﹤0.01% | 300 |
|
|
2017
Q2 | $5K | Buy |
3,943
+134
| +4% | +$170 | ﹤0.01% | 296 |
|
|
2017
Q1 | $7K | Sell |
3,809
-530
| -12% | -$974 | ﹤0.01% | 311 |
|
|
2016
Q4 | $22K | Sell |
4,339
-1,681
| -28% | -$8.52K | ﹤0.01% | 290 |
|
|
2016
Q3 | $34K | Sell |
6,020
-1,702
| -22% | -$9.61K | ﹤0.01% | 273 |
|
|
2016
Q2 | $43K | Sell |
7,722
-4,099
| -35% | -$22.8K | ﹤0.01% | 257 |
|
|
2016
Q1 | $52K | Sell |
11,821
-3,112
| -21% | -$13.7K | ﹤0.01% | 296 |
|
|
2015
Q4 | $90K | Sell |
14,933
-2,197
| -13% | -$13.2K | ﹤0.01% | 295 |
|
|
2015
Q3 | $134K | Buy |
17,130
+3,812
| +29% | +$29.8K | ﹤0.01% | 264 |
|
|
2015
Q2 | $82K | Buy |
+13,318
| New | +$82K | ﹤0.01% | 306 |
|